Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,080,207
+$62,806 QoQ
Shares Held
8,550
+17.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,040
of 2,266 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $287,466,952 across 14 Drug Manufacturers - General names. GILD ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
104,112 | $124,875,066 | |
| 2 | MRK |
Merck & Co., Inc.
|
288,700 | $37,097,950 | |
| 3 | JNJ |
Johnson & Johnson
|
127,317 | $32,334,698 | |
| 4 | AMGN |
Amgen Inc
|
55,700 | $20,170,084 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
256,790 | $14,796,239 | |
| 6 | ABBV |
AbbVie Inc.
|
53,250 | $13,399,830 | |
| 7 | OGN |
Organon & Co.
|
954,910 | $12,929,481 | |
| 8 | PFE |
Pfizer Inc
|
501,500 | $12,076,120 |
All Filings in GILD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,080,207 | 8,550 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,017,401 | 7,300 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $773,262 | 6,300 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $471,750 | 4,250 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $496,143 | 4,475 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $526,635 | 4,700 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $386,568 | 4,185 | Shares | Sole | 2025-02-13 | |
| 2023-06-30 | $2,024,705 | 26,271 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,370,535 | 28,571 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,452,820 | 28,571 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,024,727 | 32,821 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,264,038 | 36,629 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,040,859 | 34,329 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $3,040,834 | 41,879 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,938,073 | 56,379 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,744,537 | 54,379 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,430,495 | 53,079 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,715,298 | 63,771 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $6,209,744 | 98,271 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $7,607,134 | 98,871 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,718,755 | 89,871 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||